Dutchgold21 Jul 2013 09:33
Naive .. likewise this stock is valued at the SP ... ? so why buy it .. or prehaps if one of your trials is successful you may turn it round. SCLP is investing in moditope technology, any one reading the RNS can see the immunobody trial is going well. SP is not IP there is a difference ... i would also add Scancell owns the rights to moditope 100% .. you have a lot to learn, wait the August RNS best of luck as ever here. If there was so much interest here, why is it i can fit a months trades on one page ?